Comparison between Surevin BPO IPO and Vaishali Pharma IPO.
Surevin BPO IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Vaishali Pharma IPO is a SME Bookbuilding proposed to list at NSE SME.
| Surevin BPO IPO | Vaishali Pharma IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Hem Securities Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Sharex Dynamic (India) Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Hem Finlease Pvt.Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Surevin BPO IPO is up to ₹3.46 Cr whereas the issue size of the Vaishali Pharma IPO is up to ₹13.48 Cr. The final issue price of Surevin BPO IPO is ₹40.00 per share and of Vaishali Pharma IPO is ₹72.00 per share.
| Surevin BPO IPO | Vaishali Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹38.00 per share | ₹71.00 per share |
| Issue Price (Upper) | ₹40.00 per share | ₹72.00 per share |
| Issue Price (Final) | ₹40.00 per share | ₹72.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 8,64,000 shares | 18,72,000 shares |
| Fresh Issue Size (Amount) | up to ₹3.46 Cr | up to ₹13.48 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 8,64,000 shares | 18,72,000 shares |
| Issue Size Total (Amount) | up to ₹3.46 Cr | up to ₹13.48 Cr |
Surevin BPO IPO opens on Jul 28, 2017, while Vaishali Pharma IPO opens on Aug 07, 2017. The closing date of Surevin BPO IPO and Vaishali Pharma IPO is Aug 01, 2017, and Aug 10, 2017, respectively.
| Surevin BPO IPO | Vaishali Pharma IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jul 28, 2017 | Aug 07, 2017 |
| Issue Close | Aug 01, 2017 | Aug 10, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 09, 2017 | Aug 22, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Surevin BPO IPO P/E ratio is , as compared to Vaishali Pharma IPO P/E ratio of .
| Surevin BPO IPO | Vaishali Pharma IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹13.55 Cr. | ₹47.46 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Surevin BPO IPO Retail Individual Investors (RII) are offered 4,32,000 shares while in Vaishali Pharma IPO retail investors are offered 4,32,000 shares. Qualified Institutional Buyers (QIB) are offered in Surevin BPO IPO and in Vaishali Pharma IPO.
| Surevin BPO IPO | Vaishali Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 48,000 shares | 1,04,000 shares |
| QIB | ||
| NII | 4,32,000 shares | 9,36,000 shares |
| RII | 4,32,000 shares | 9,36,000 shares |
| Employee | ||
| Others | ||
| Total | 8,64,000 shares | 18,72,000 shares |
Surevin BPO IPO subscribed 58.46x in total, whereas Vaishali Pharma IPO subscribed 2.00x.
| Surevin BPO IPO | Vaishali Pharma IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 79.29x | 1.98x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 36.83x | 2.02x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 58.46x | 2.00x |
